Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023.
Carlos Abud-MendozaFrancisco Javier Aceves-ÁvilaCésar Alejandro Arce-SalinasJosé Álvarez NemegyeiLeonor Barile-FabrisSergio Durán-BarragánDiana Elsa Flores-AlvaradoEufrates Hernández-NúñezFedra Irazoque-PalazuelosJosé Francisco Moctezuma-RíosVirginia Pascual-RamosMargarita Portela-HernándezLuis Humberto SilveiraLilia Andrade-OrtegaAna Barrera-VargasSandra Carrillo-VázquezZully Castro-ColinEnrique Cuevas-OrtaLuis Felipe Flores-SuárezGuillermo Arturo Guaracha-BasáñezMaría Fernanda Hernández-CabreraIván de Jesús Hernández-GalarzaDavid Alejandro Herrera-vanOostdamAdriana Concepción Lobato-BelmonteLaura Aline Martínez-MartínezMarco Ulises Martínez-MartínezGabriel Medrano-RamírezFrancisco Javier Merayo-ChalicoGraciela Meza-López Y OlguínFrancisco OlanGenaro Peña-SantosCésar Ramos-RemusGreta Reyes-CorderoVijaya Rivera-TeránJorge Rojas-SerranoGriselda Serna-PeñaSandra Sicsik-AyalaCésar Armando Sifuentes-CantúDavid Vega-MoralesPablo Villaseñor-OviesDaniel Xibillé-FriedmannCésar Pacheco-TenaPublished in: Reumatologia clinica (2024)
This update of the Mexican guidelines for the pharmacological treatment of RA provides reference points for evidence-based decision-making, recommending patient participation in joint decision-making to achieve the greatest benefit for our patients. It also establishes recommendations for managing a variety of relevant conditions affecting our patients.